ReachMD

Dr. Donald Robinson, professor of psychiatry and former chairman in the department of pharmacology at Marshall University School Of Medicine and professor of pharmacology and medicine at the University Of Vermont School Of Medicine is a consultant with Worldwide Drug Development in Burlington, Vermont. Prior to his role as a consultant, Dr. Robinson was the vice president of CNS Clnical Research at Bristol-Myers Squibb Company in which he headed up the central nervous system drug development and also worked on development and marketing for several other drugs. 

Dr. Robinson has published more than 175 scientific/medical articles on monoamine oxidase inhibitor, antidepressant, anxiolytic, antipsychotic, and hypnotic agents as well as clinical trial methodology.